NASDAQ · Biotechnology
Moderna Inc (MRNA)
$195.00
-2.17%
43
In band
Moving averages
SMA 200$93.58+108.38%
Company profile
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$100.63B
P/E ratioNone
EPS$-6.98
Beta1.166
Dividend yield0.00%
52-week high$280.80
52-week low$22.28
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
TECH
Bio-Techne Corp
RSI 55
BMRN
Biomarin Pharmaceutical Inc
RSI 64
IBRX
ImmunityBio Inc
RSI 40
TARS
Tarsus Pharmaceuticals Inc
RSI 54
VKTX
Viking Therapeutics Inc
RSI 44
ATAI
ATAI Life Sciences N.V.
RSI 62
RSI alerts for MRNA
An email when MRNA closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 2:55 AM EST